Skip to main content

Covid-19: Need felt for better reporting to assess impact of traditional medicines

By Rosamma Thomas* 

On February 17, 2023, the journal Frontiers in Medicine carried an analysis of the reporting of registered Covid-19 clinical trials of Chinese and traditional Indian medicine. The study included research registered on clinical trial registries in India and China before February 10, 2021; almost 34% of all trials registered in China were of traditional medicine, while over 58% of Clinical Trial Registry-India were of traditional systems of medicine. 
For purposes of comparison, conventional medicine studies from India, China and other countries were considered. Authors Nan Zhao of the School of Nursing of the Nanjing Medical University, China, Kritika Pandey of Integrative Ayurveda Network, Leicester, UK, Skanthesh Lakshmanan of the School of Public Health, Nanjing Medical University, Ran Zhao of the School of Public Health, Gansu University of Traditional Chinese Medicine, China, Jingchun Fan, Evidence-Based Medicine Centre, Tianjin University of Traditional Chinese Medicine and others concluded, through Cox regression analysis traditional medicine trials were less likely to be reported than trials of conventional medicine.
Pharmacological, alternative, dietary, immunological, vaccine, stem cell, digital health, ventilation, physical therapy, behavioural or psychological interventions were studied, and Ayurveda, yoga, naturopathy, Unani, Siddha and homeopathy were considered as part of the Indian registered trials.
This is an interesting piece of research, for the authors have also noted the potential for benefit from traditional medicine for non-severe Covid-19 cases. 
“The potential benefits of TCM (traditional Chinese medicine) treatments may result from their direct antiviral activities but, arguably more likely, by balancing the immune system and alleviating the harmful cytokine storm,” the researchers note. “We found that registered trials of traditional Indian medicine were more likely to be targeted on non-severe Covid-19 cases or individuals without Covid-19 illness, which might be due to the perceived preventive mechanisms of Ayurvedic formulations.”
What was also interesting was that few of the traditional medicine studies had patients with “severe Covid-19”. About 8% of the trials in both India and China were either abruptly terminated or did not start at all. “Reasons given for not starting or early terminating registered trials included mainly difficulty recruiting participants after suppression of Covid-19 outbreaks, availability of new evidence from other research, and possible harmful effects of treatments evaluated.” 
There were no proven treatments during the early stage of the so-called pandemic, and healthcare professionals relied on previous experience or repurposed interventions. The researchers note that the traditional medicine trials were often “underpowered, poorly designed, and unlikely to provide valid and relevant evidence.”
Many of the Chinese trials were also retrospectively registered. The researchers also note that pre-print publication of traditional medicine trials is rare; they noted that empirical evidence also indicated “publication related bias where positive or favourable results were more likely to be reported.”
The need for more rigorous trials and more frequent reporting, even of trials that fail, is underlined by the researchers. This is even more pressing in light of the severe flaws in the global health system, and the manipulation of data and news media that was witnessed during the so-called Covid-19 pandemic. “How were populations cajoled into accepting the official Covid narrative?” asks journalist Colin Todhunter, who reports on an analysis of global data presented by Bhaskaran Raman, associate professor at the Department of Computer Science and Engineering at the Indian Institute of Technology, Bombay, who made a presentation at the Dr DY Patil Medical College, Hospital and Research Centre at Pune.
In March 2023 British Medical Journal reported that patients were suing AstraZeneca over the side-effects of the Covid-19 vaccine. Around 75 claimants – either survivors of the vaccine or those who have lost relatives to it – were part of the legal process.
Given the manipulation of the media and the preponderance of the pharmaceutical industry even in the clinical trial process, it is even more important that individuals assert their right to decide what is best for their health – a right enshrined in the Nuremburg Code.
---
*Freelance journalist

Comments

TRENDING

Wave of disappearances sparks human rights fears for activists in Delhi

By Harsh Thakor*  A philosophy student from Zakir Hussain College, Delhi University, and an activist associated with Nazariya magazine, Rudra, has been reported missing since the morning of July 19, 2025. This disappearance adds to a growing concern among human rights advocates regarding the escalating number of detentions and disappearances of activists in Delhi.

How community leaders overcome obstacles to protect forests and pastures in remote villages

By Bharat Dogra  Dheera Ram Kapaya grew up in such poverty that, unable to attend school himself, he would carry another boy’s heavy school bag for five kilometers just to get a scoop of daliya (porridge). When he was finally able to attend school, he had to leave after class five to join other adolescent workers. However, as soon as opportunities arose, he involved himself in community efforts—promoting forest protection, adult literacy, and other constructive initiatives. His hidden talent for writing emerged during this time, and he became known for the songs and street play scripts he created to promote forest conservation, discourage child marriages, and support other social reforms.

‘Act of war on agriculture’: Aruna Rodrigues slams GM crop expansion and regulatory apathy

By Rosamma Thomas*  Expressing appreciation to the Union Agriculture Minister for inviting suggestions from farmers and concerned citizens on the sharp decline in cotton crop productivity, Aruna Rodrigues—lead petitioner in the Supreme Court case ongoing since 2005 that seeks a moratorium on genetically modified (GM) crops—wrote to Union Minister Shivraj Singh Chouhan on July 14, 2025, stating that conflicts of interest have infiltrated India’s regulatory system like a spreading cancer, including within the Indian Council for Agricultural Research (ICAR).

The GMO illusion: Three decades of hype, harm, and false hope

By Sridhar Radhakrishnan  Three decades of hype, billions of dollars spent, and still no miracle crop. It's time to abandon the GMO biotech fairy tale and return to the soil, the seed, and the farmer. “Trust us,” they said. “GMOs will feed the world.” Picture a world where there is plenty of food, no hunger, fields grow without chemical pesticides, children are saved from malnutrition, and people live healthily.

Overriding India's constitutional sovereignty? Citizens urge PM to reject WHO IHR amendments

By A Representative   A group of concerned Indian citizens, including medical professionals and activists, has sent an urgent appeal to Prime Minister Narendra Modi, urging him to reject proposed amendments to the International Health Regulations (IHR) before the ratification deadline of July 19, 2025. 

Sandra Gonzalez Sanabria: An inspiring life from Colombia’s Amazonian valley

By Vidya Bhushan Rawat*  In the village of Héctor Ramírez, known as Agua Bonita, in La Montañita, Caquetá, Colombia, a vision of peace and renewal is unfolding. In the pre-2016 period, this would have been nearly impossible for outsiders to visit, as it was the epicenter of violent resistance against state oppression. However, after the Peace Accord was signed between the Colombian government and former revolutionaries—marking the end of a 70-year insurgency that claimed over 400,000 lives until 2025, including civilians, rebel fighters, and security personnel—things began to change. Visiting Agua Bonita during the Global Land Forum in Bogotá revealed a village of hope and resilience. Former FARC revolutionaries have settled here and transformed the village into a center of peace and aspiration.

Indigenous Karen activist calls for global solidarity amid continued struggles in Burma

By A Representative   At the International Festival for People’s Rights and Struggles (IFPRS), Naw Paw Pree, an Indigenous Karen activist from the Karen Human Rights Group (KHRG), shared her experiences of oppression, resilience, and hope. Organized with the support of the International Indigenous Peoples Movement for Self-Determination and Liberation (IPMSDL), the event brought together Indigenous and marginalized communities from across the globe, offering a rare safe space for shared learning, solidarity, and expression.

Activists allege abduction and torture by Delhi Police Special Cell in missing person probe

By A Representative   A press statement released today by the Campaign Against State Repression (CASR) alleges that several student and social activists have been abducted, illegally detained, and subjected to torture by the Delhi Police Special Cell. The CASR claims these actions are linked to an investigation into the disappearance of Vallika Varshri, an editorial team member of 'Nazariya' magazine.

India’s zero-emission, eco-friendly energy strategies have a long way to go, despite impressive progress

By N.S. Venkataraman*   The recent report released by OPEC’s World Oil Outlook 2025 has predicted that by the year 2050, crude oil would replace coal as India’s key energy source. Clearly, OPEC expects that India’s dependence on fossil fuels for energy will continue to remain high in one form or another.